Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 27/09/20181 min de lecture
Coronary Drug-Eluting Stents-Nonclinical and Clinical Studies and Companion Guidance Document; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Reopening of the Comment Period
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice of availability, published in the Federal Register of March 27, 2008. In that document, FDA requested comments on two draft guidance documents entitled "Coronary Drug-Eluting Stents--Nonclinical and Clinical Studies" and "Coronary Drug-Eluting Stents--Nonclinical and Clinical Studies Draft Companion Guidance Document." The Agency is reopening the comment period to allow interested persons to provide updated comments and any new information.
Langue originale de la source: Federal Register — Food and Drug AdministrationOuvrir le communiqué original →